Rheumatologist: Flexible PTO & High-Tech Clinic Infusions
Top Echelon Software LLC
Une candidature complète en une minute
Un CV et une lettre de motivation personnalisés, prêts à envoyer.
Avantages offerts par ce poste
Résumé du poste
Top Echelon Software LLC in Munster, IN is seeking a Rheumatologist for a full-time, Monday–Friday role with a 1:3 call rotation. This premier healthcare facility emphasizes physician well-being and a sustainable work-life balance in a tech-forward, HIMSS Stage VII environment.
Responsibilities include managing autoimmune and inflammatory disorders, supervising infusion services, and performing joint aspirations and ultrasound-guided injections, while educating patients on disease progression
Qualifications
- Board certification in Rheumatology; eligible for certification within a defined timeframe.
- Indiana medical license or license eligibility with CSR/DEA registration.
- Experience with EPIC EMR and AI-assisted documentation tools.
- Strong interpersonal skills for collaboration with other specialists.
Responsabilités
- Provide diagnostic, treatment, and management for autoimmune/inflammatory disorders (RA, lupus, OA, vasculitis).
- Manage high-volume outpatient clinic focusing on chronic disease and complex autoimmune cases.
- Oversee in-office infusion services, including biologic therapies administration and monitoring.
- Perform joint aspirations, ultrasound-guided injections, and soft tissue injections.
- Educate patients on long-term disease progression, medication safety, and lifestyle modifications.
Connaissances
Formation
Outils
Description du poste
Top Echelon Software LLC in Munster, IN is seeking a Rheumatologist for a full-time, Monday–Friday role with a 1:3 call rotation. This premier healthcare facility emphasizes physician well-being and a sustainable work-life balance in a tech-forward, HIMSS Stage VII environment.
Responsibilities include managing autoimmune and inflammatory disorders, supervising infusion services, and performing joint aspirations and ultrasound-guided injections, while educating patients on disease progression
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
